Jane Street Group, LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $49.4 Million - $54.3 Million	107,400 New	107,400 $49.9 Million
Q1 2022 May 17, 2022	SELL	$221.42 - $260.97 $5.27 Million - $6.21 Million	-23,800 Reduced 10.45%	204,000 $53.2 Million
Q4 2021 Feb 15, 2022	BUY	$177.01 - $223.45 $9.42 Million - $11.9 Million	53,200 Added 30.47%	227,800 $50 Million
Q3 2021 Nov 16, 2021	SELL	$181.39 - $202.99 $707,421 - $791,661	-3,900 Reduced 2.18%	174,600 $31.7 Million
Q1 2021 May 18, 2021	BUY	$207.02 - $241.31 $23.3 Million - $27.2 Million	112,600 Added 170.86%	178,500 $38.4 Million
Q4 2020 Feb 17, 2021	BUY	$207.01 - $276.09 $3.17 Million - $4.22 Million	15,300 Added 30.24%	65,900 $15.6 Million
Q3 2020 Nov 17, 2020	SELL	$255.65 - $303.1 $37 Million - $43.9 Million	-144,700 Reduced 74.09%	50,600 $13.8 Million
Q2 2020 Aug 17, 2020	BUY	$225.48 - $295.8 $29.6 Million - $38.8 Million	131,100 Added 204.21%	195,300 $56.7 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $7.01 Million - $8.7 Million	35,100 Added 120.62%	64,200 $15.3 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $5.68 Million - $7.64 Million	-34,100 Reduced 53.96%	29,100 $6.37 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $7.03 Million - $7.91 Million	42,300 Added 202.39%	63,200 $10.7 Million
Q2 2019 Aug 15, 2019	SELL	$164.61 - $190.37 $1.25 Million - $1.45 Million	-7,600 Reduced 26.67%	20,900 $3.83 Million
Q1 2019 May 16, 2019	BUY	$163.73 - $194.7 $1.87 Million - $2.22 Million	11,400 Added 66.67%	28,500 $5.24 Million
Q4 2018 Feb 15, 2019	SELL	$151.91 - $192.21 $1.88 Million - $2.38 Million	-12,400 Reduced 42.03%	17,100 $2.83 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $2.26 Million - $2.6 Million	-13,500 Reduced 31.4%	29,500 $5.69 Million
Q2 2018 Aug 15, 2018	BUY	$145.72 - $169.96 $3.16 Million - $3.69 Million	21,700 Added 101.88%	43,000 $7.31 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $2.08 Million - $2.43 Million	13,700 Added 180.26%	21,300 $3.47 Million
Q4 2017 Feb 15, 2018	SELL	$137.28 - $155.55 $4.98 Million - $5.65 Million	-36,300 Reduced 82.69%	7,600 $1.14 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $6.5 Million - $7.12 Million	43,900	43,900 $6.68 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$10.9 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$9.45 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$8.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$4.82 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$3.67 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account